Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer (DRPC).
Christoph W. Reuter
No relevant relationships to disclose
Michael A. Morgan
No relevant relationships to disclose
Viktor Gruenwald
No relevant relationships to disclose
Martin Fenner
No relevant relationships to disclose
Philipp Ivanyi
No relevant relationships to disclose
Arnold Ganser
No relevant relationships to disclose